Clue receives FDA clearance for a form of digital contraception

Article Edited by | Jhon N |


Clue, a company that is famous for tracking your period, has received from the Food and Drug Administration for a digital birth control function.

Clue, best known for its Period tracking app, announced that its digital birth control function received FDA approval.

“It will become more meaningful over time.” So as the individual puts in their cycles, then we will personalise the intake threshold of their high risk days versus their low risk days,” Clue's Chief Medical Officer Lynae Brayboy said.

The company has plans to launch digital birth control feature some time this year.

Clue's trial data shows that its method is almost 99 percent effective as most people do it. The statistical modelling used by Clue was developed by the Institute for Reproductive Health at Georgetown University and tested by Cycle Technologies, which was acquired by Clue in 2019.

This is another form of birth control approved by the FDA.

This is the second method of birth control that has been cleared by the United States Food and Drug Administration (FDA) as a method of contraception. The first method requires you to take your body temperature each morning. Its 2018 appraisal was distressing - it came when the app was acclaimed for wanted pregnancies in Sweden.

The birth control device that has been released by Clue will be marketed as "substantially equivalent to" other birth control products already on the market. Regarding Clue's product, it was considered that it was similar enough to Natural Cycles. According to Natural Cycles CEO Elina Berglund, the company will analyse Clue tests. According to the "FDA filing", "Natural Cycles" is proven to be more effective than other products based solely on a user's menstrual cycle data.

It is related to the fertility awareness method, when people track metrics like the days they menstruate, their temperature, and changes to their cervical mucus to predict when they can become pregnant. You should try to implement these methods when you are more patient and eager. Both men and women can make use of the new methods that help in reducing the probabilities of conceiving.

If someone becomes ineligible, or if their cycle becomes too irregular, the app will shut down their account.

Only people who are 18 to 45 years old and who have regular menstrual cycles, should utilise Clue's health management service. If someone is not eligible, but their cycle becomes irregular, the application will lock them out.

Clue previously has a function that predicted the day of and days leading up to ovulation. The app recommended that the favourable hormone feature should not be used as an alternative to contraception but could help those who wish to conceive. The company removed the feature stating that it is not so accurate “We determined that the female fertile window was misleading to those wishing to avoid pregnancy,” it wrote in a blog post. "We hope to implement this in the near future."